Autres langues Recursion Pharmaceuticals, Inc.

Actions

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 26/04/2024			Varia. 5j.	Varia. 1 janv.
8,12 ^USD	+3,57%		+10,48%	-17,65%

18/04	Un initié de Recursion Pharmaceuticals a vendu des actions pour une valeur de 367 007 $, selon un récent dépôt auprès de la SEC	MT
16/04	Recursion nomme Najat Khan au poste de directeur de la recherche et du développement et de directeur commercial	CI

Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing	18/04
Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer	16/04
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer	16/04
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer	16/04
Recursion Appoints Najat Khan as Chief R&D Officer and Chief Commercial Officer	16/04
Recursion to Participate in Upcoming Investor Conference	02/04
Recursion to Participate in Upcoming Investor Conference	02/04
Recursion Publishes Annual Environmental, Social and Governance Report	26/03
50 valores para invertir en IA, salud, movilidad y energía	25/03
50 aandelen om te beleggen in KI, gezondheid, mobiliteit en energie	23/03
50 titoli per investire in AI, salute, mobilità ed energia	22/03
50 Top-Aktien für Investitionen in KI, Gesundheit, Mobilität und Energie	22/03
Recursion Pharmaceuticals Insider Sold Shares Worth $537,190, According to a Recent SEC Filing	15/03
Recursion Pharmaceuticals to Open London Office	11/03
Recursion Announces Plans to Open New Office in London	11/03
Recursion Announces Plans to Open New Office in London	11/03
Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community	01/03
Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community	01/03
Recursion to Participate in Upcoming Investor Conferences	01/03
Recursion to Participate in Upcoming Investor Conferences	01/03

Aucun résultat pour cette recherche